Balyasny Asset Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,368,474	Closed	-$8.25M	–	3634
2025 Q4	$8.25M	Buy	+1,368,474	New	+$8.15M	0.02%	1121
2025 Q2	–	Sell	-266,005	Closed	-$1.72M	–	3446
2025 Q1	$1.72M	Buy	266,005 +209,221	+368%	+$1.86M	﹤0.01%	1770
2024 Q4	$417K	Buy	56,784 +30,351	+115%	+$239K	﹤0.01%	2258
2024 Q3	$198K	Buy	+26,433	New	+$230K	﹤0.01%	2571
2023 Q4	–	Sell	-235,604	Closed	-$2.21M	–	2968
2023 Q3	$2.21M	Sell	235,604 -283,248	-55%	-$4.04M	0.01%	1355
2023 Q2	$12.7M	Buy	518,852 +115,904	+29%	+$2.91M	0.04%	675
2023 Q1	$9.38M	Buy	+402,948	New	+$10.3M	0.03%	807
2022 Q4	–	Sell	-385,146	Closed	-$7.43M	–	3328
2022 Q3	$7.43M	Buy	385,146 +374,897	+3,658%	+$9.53M	0.03%	822
2022 Q2	$261K	Buy	+10,249	New	+$239K	﹤0.01%	2137
2022 Q1	–	Sell	-218,710	Closed	-$9.16M	–	2944
2021 Q4	$9.16M	Buy	218,710 +191,899	+716%	+$7.52M	0.04%	660
2021 Q3	$1.17M	Buy	26,811 +7,468	+39%	+$323K	0.01%	1291
2021 Q2	$915K	Buy	+19,343	New	+$879K	0.01%	1327
2020 Q2	–	Sell	-91,977	Closed	-$3.15M	–	1567
2020 Q1	$3.15M	Buy	+91,977	New	+$2.47M	0.04%	514